Elicio Therapeutics Inc (ELTX)
9.20
+0.10
(+1.10%)
USD |
NASDAQ |
Apr 30, 16:00
9.15
-0.05
(-0.54%)
After-Hours: 20:00
Elicio Therapeutics Price: 9.20 for April 30, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Apr 30, 2024 | 9.15 | 9.20 | 8.858 | 9.20 | 57116.00 |
Apr 29, 2024 | 9.05 | 9.15 | 8.90 | 9.10 | 49179.00 |
Apr 26, 2024 | 9.15 | 9.15 | 8.82 | 8.99 | 37127.00 |
Apr 25, 2024 | 9.20 | 9.20 | 9.00 | 9.10 | 19886.00 |
Apr 24, 2024 | 9.29 | 9.47 | 9.12 | 9.25 | 24650.00 |
Apr 23, 2024 | 9.62 | 9.62 | 9.20 | 9.22 | 19431.00 |
Apr 22, 2024 | 8.60 | 9.90 | 8.34 | 9.74 | 68337.00 |
Apr 19, 2024 | 8.21 | 8.99 | 8.052 | 8.40 | 27899.00 |
Apr 18, 2024 | 9.30 | 9.30 | 7.98 | 8.23 | 43238.00 |
Apr 17, 2024 | 9.84 | 9.84 | 8.83 | 9.30 | 40605.00 |
Apr 16, 2024 | 9.30 | 9.64 | 9.26 | 9.63 | 29158.00 |
Apr 15, 2024 | 10.22 | 10.44 | 8.805 | 9.23 | 140771.0 |
Apr 12, 2024 | 9.79 | 9.90 | 9.05 | 9.85 | 134927.0 |
Apr 11, 2024 | 8.85 | 9.89 | 8.61 | 9.89 | 71718.00 |
Apr 10, 2024 | 9.42 | 9.42 | 8.40 | 8.77 | 66417.00 |
Apr 09, 2024 | 9.49 | 9.49 | 8.529 | 8.80 | 80053.00 |
Apr 08, 2024 | 9.20 | 9.88 | 8.645 | 8.66 | 138237.0 |
Apr 05, 2024 | 7.63 | 9.02 | 7.42 | 8.85 | 95268.00 |
Apr 04, 2024 | 7.37 | 7.62 | 7.28 | 7.52 | 31930.00 |
Apr 03, 2024 | 7.50 | 7.55 | 6.900 | 7.37 | 46012.00 |
Apr 02, 2024 | 7.19 | 7.60 | 6.785 | 7.42 | 37378.00 |
Apr 01, 2024 | 6.83 | 7.487 | 6.522 | 7.12 | 37918.00 |
Mar 28, 2024 | 7.46 | 7.80 | 7.35 | 7.60 | 46460.00 |
Mar 27, 2024 | 7.06 | 7.46 | 7.02 | 7.46 | 43328.00 |
Mar 26, 2024 | 7.07 | 7.19 | 6.30 | 7.10 | 51212.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
3.30
Minimum
Jan 24 2024
18.14
Maximum
Jun 02 2023
7.716
Average
7.42
Median
Apr 02 2024
Price Benchmarks
Immuneering Corp | 1.42 |
Oragenics Inc | 1.035 |
Outlook Therapeutics Inc | 8.92 |
Amylyx Pharmaceuticals Inc | 1.81 |
NovaBay Pharmaceuticals Inc | 0.0808 |
Price Related Metrics
Price to Book Value | 8.223 |
Earnings Yield | -279.7% |
Market Cap | 93.52M |